Powered by breakthrough technology, our vision of a mouth-watering, affordable and healthy protein is fast approaching - we’ve pioneered a strategy to scale cultivated meat that eliminates the industry’s largest cost driver with zero genetic engineering.

Previously known as Higher Steaks Ltd, we’ve successfully scaled from a compact start-up to a dynamic company of 50+ creative scientists, engineers and operators, committed to a massive takeover of the food industry. We’ve developed a scalable production process that can cut costs, drastically reduce waste materials and improve the health of consumers.

We’ve raised capital totalling $37M from Balderton, Lowercarbon Capital, RedAlpine, Sam Altman (Open AI founder) and Max Altman as well as the UK government through a $1.2M Innovate UK grant. 

From the cell to the sizzle, our Uncommon Bacon and Uncommon Belly are packed full of nutritious goodness and fantastic flavour; paving the way for an Uncommonly good future of delicious, healthy and sustainable meat.

Unleash your creativity and join us!


The Pearse Lyons Accelerator

Dismatrix Group / Planthesis Fund

Balderton Capital

Redalpine

East Alpha

Lowercarbon Capital

Danielle Walsh

Max Altman

Miray Zaki

Sam Altman

Sebastiano Cossia Castiglioni

Uncommon

Recursion Pharmaceuticals is a biotech company focused on drug discovery and development using advanced computational methods.

Recursion Pharmaceuticals

Pepper Bio is a drug discovery company that provides actionable insights using computational methods.

Pepper Bio

Aitia is a company involved in advanced computational drug discovery methods.

Aitia

Terray Therapeutics is a biotech company focused on leveraging computational methods for drug discovery and development.

Terray Therapeutics

Ardigen is a company focusing on drug discovery and development using advanced computational methods.

Ardigen

Insitro is a company specializing in drug discovery and development through advanced computational techniques.

Insitro

Rebiotix is a company involved in drug discovery and development with a focus on computational methods.

Rebiotix

Gritstone Bio is a biotech company focused on drug discovery and development using advanced computational methods.

Gritstone Bio

Arkuda Therapeutics is a biotechnology company leveraging new insights into progranulin and lysosomal biology to develop medicines for drug discovery.

Arkuda Therapeutics

Uncommon Bio is a biotechnology company focused on the development of advanced computational methods and technologies to understand and engineer complex biological systems. Their work aims to revolutionize drug discovery and development by leveraging machine learning and other cutting-edge computational techniques.

Uncommon Bio

news_impact_assignment_basic

key_people

merger_acquisitions

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general	May 7, 2024 12:36 PM	3aff262f
public peers	general	May 7, 2024 12:36 PM	77265488
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general	May 7, 2024 12:36 PM	57996b76
company summary	general
signals	general
crunchbase trigger	general	Nov 27, 2024 12:50 PM	b98827c2
crunchbase profile	general
li profile	general	May 7, 2024 12:36 PM	3d1bd92e
translate crunchbase fundingrounds	general
peers	general
news basic	general	May 7, 2024 12:36 PM	90135e97
bundesanzeiger	filings
financials download nd	financials
private financials	financials

CO:UNCOMMONBIO

Uncommon Bio